These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 3707641

  • 1. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L, Ghirardi P, Brusoni B, Mussini E, Marchetti G.
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [Abstract] [Full Text] [Related]

  • 2. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA, Ohlstein EH, Ruffolo RR.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [Abstract] [Full Text] [Related]

  • 3. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
    Musacci GF, Ansani L, Toselli T, Aggio S, Baracca E, Longhini C.
    Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
    [Abstract] [Full Text] [Related]

  • 4. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
    Marchetti G, Merlo L.
    Arzneimittelforschung; 1986 Feb; 36(2A):331-3. PubMed ID: 3707644
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A, Mussini A, Bramucci E.
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ, Smith JM, Shebuski RJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [Abstract] [Full Text] [Related]

  • 7. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C, Compostella L, Iavernaro A, Libardoni M, Ghirardi P, Cucchini F.
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [Abstract] [Full Text] [Related]

  • 8. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD.
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L, Ibba GV, Castellaccio M, Dore L.
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic response to ibopamine in acute myocardial infarction.
    Taniguchi H, Iwasaka T, Sugiura T, Takayama Y, Sumimoto T, Onoyama H, Takashima H, Nakamura S, Inada M.
    Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M, Takasuna K, Yamashita N, Tamura K.
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C, Triulzi E, Devizzi S, Colombo G, Palvarini M, Pocchiari F, Pataccini R.
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
    Shebuski RJ, Fujita T, Smith JM, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F, Morgera T, Maras P, Camerini F.
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [Abstract] [Full Text] [Related]

  • 16. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
    Seymour AA, Blaine EH.
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L, Metra M, Nodari S, Visioli O.
    J Cardiovasc Pharmacol; 1989 Jun; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [Abstract] [Full Text] [Related]

  • 18. The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies.
    Ciampani N, Massacci C, Capestro F, Breccia Fratadocchi G, Mocchegiani R, Ruga O, Purcaro A.
    Arzneimittelforschung; 1986 Feb; 36(2A):363-6. PubMed ID: 3707651
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
    Ohhara H, Ogawa T, Takeda M, Katoh H, Daiku Y, Igarashi T.
    Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H.
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.